Related Experiment Video
Updated: Dec 26, 2025

Detection of Signaling Effector-Complexes Downstream of BMP4 Using in situ PLA, a Proximity Ligation Assay
Published on: March 3, 2011
Controlling Smad4 signaling with a Wip
Peter Ten Dijke1, David Baker1
1Department Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.
Abstract:
Members of the transforming growth factor-β (TGF-β) family play key roles in embryogenesis and in maintaining tissue homeostasis, and their perturbation can result in a broad range of diseases. One way TGF-β family signaling pathways are kept in check is by reversible (de)phosphorylation of intracellular Smad effectors. In this issue of EMBO Reports, Park et al [1] identify the phosphatase wild-type p53-induced phosphatase 1 (Wip1) as a negative regulator of TGF-β family signaling. Mechanistically, Wip1 constrains TGF-β family signaling through direct dephosphorylation of Thr277, an activating MAP kinase phosphorylation site located in the linker region of the common mediator Smad4.
Insights
Wild-type p53-induced phosphatase 1 (Wip1) negatively regulates transforming growth factor-β (TGF-β) signaling. Wip1 dephosphorylates Smad4 at Thr277, a key site controlling TGF-β pathway activity.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Signal transduction
Background:
- Transforming growth factor-β (TGF-β) family signaling is crucial for development and tissue homeostasis.
- Dysregulation of TGF-β signaling is implicated in various diseases.
- Intracellular Smad proteins mediate TGF-β family signals and are regulated by phosphorylation.
Discussion:
- Park et al. identify wild-type p53-induced phosphatase 1 (Wip1) as a novel negative regulator of TGF-β family signaling.
- Wip1 directly dephosphorylates Smad4 at the Thr277 site.
- This dephosphorylation event occurs at an activating MAP kinase phosphorylation site in Smad4's linker region.
Key Insights:
- Wip1 acts as a critical brake on TGF-β family signaling.
- The phosphatase activity of Wip1 on Smad4's Thr277 site is a key mechanism for controlling pathway flux.
- This finding reveals a new layer of regulation within the Smad-mediated signaling cascade.
Outlook:
- Understanding Wip1's role in TGF-β signaling may offer new therapeutic targets for diseases associated with pathway dysregulation.
- Further research could explore the upstream regulation of Wip1 in the context of TGF-β signaling.
- Investigating the interplay between Wip1 and other Smad-modifying enzymes could elucidate broader signaling network dynamics.
Related Concept Videos
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Canonical Wnt Signaling Pathway
Hedgehog Signaling Pathway
Non-Canonical Wnt Signaling Pathways
PI3K/mTOR/AKT Signaling Pathway

